Efficacy and Safety of Dual-Drug-Eluting Stents for de Novo Coronary Lesions in South Korea—The Effect Trial

Efficacy and Safety of Dual-Drug-Eluting Stents for de Novo Coronary Lesions in South Korea—The Effect Trial

Background: Drug-eluting stents (DESs) are commonly used in percutaneous coronary intervention (PCI) procedures; however, complications including in-stent restenosis and stent thrombosis are significant challenges. The dual-DES is a stent that elutes two drugs to target various stages of the resteno...

Full description

Bibliographic Details
Main Authors:	Jung-Joon Cha, Gi Chang Kim, Seung Ho Hur, Jang Ho Bae, Jae Woong Choi, Dong-Kyu Jin, Seong Il Woo, Seung Uk Lee, Jong Seon Park, Yun-Hyeong Cho, Cheol Ung Choi, Do-Sun Lim, Tae Hoon Ahn
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Journal of Clinical Medicine
Subjects:	dual drug-eluting stent Cilotax<sup>™</sup> stent DXR<sup>™</sup> stent coronary artery disease clinical outcome
Online Access:	https://www.mdpi.com/2077-0383/10/1/69

Similar Items

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

Influence of Cooling Conditions on Long-Period Stacking-Ordered Phase Evolution and Corrosion Behavior of As-Cast Resoloy<sup>®</sup>
by: Sandra Ahlers, et al.
Published: (2021-08-01)

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature
by: Prashanth Panduranga, et al.
Published: (2011-01-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
by: Damian Maciejewski, et al.
Published: (2019-09-01)

Endovascular Treatment with Limus Eluting Stents in Patients with Acute Coronary Syndrome
by: M. V. Chernyayev, et al.
Published: (2019-04-01)

The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence
by: Alberto Chisari, et al.
Published: (2016-09-01)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
by: Jorge A Arroyave C, et al.
Published: (2012-06-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Aslı Tanındı, et al.
Published: (2015-07-01)

Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis
by: Leos Pleva, et al.
Published: (2017-06-01)

Erosion/malapposition of a sirolimus eluting stent – Optical coherence tomography image – A case report
by: G. Sengottuvelu
Published: (2012-11-01)

Compatible Stability and Aerosol Characteristics of Atrovent<sup>®</sup> (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine
by: Yiting Chen, et al.
Published: (2020-08-01)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

Comparison of 3-year clinical outcomes between Endeavor Resolute® and Resolute Integrity® zotarolimus-eluting stents in an Asian population
by: Yong Hoon Kim, et al.
Published: (2020-04-01)

Stent thrombosis with an aneurysm 7 years after a drug eluting stent implantation
by: Pritam Patil, et al.
Published: (2014-03-01)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
by: Mohamed Aboel-Kassem F. Abdelmegid, et al.
Published: (2017-04-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Endrin Koni, et al.
Published: (2021-03-01)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
by: Ganesh Paramasivam, et al.
Published: (2019-11-01)

Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis: An Updated Systematic Review and Meta-Analysis
by: Kong-Yong Cui, et al.
Published: (2018-01-01)

Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions
by: Wonsuk Choi, et al.
Published: (2019-07-01)

POR QUÉ USAR PREFERENTEMENTE STENTS NO FARMACOACTIVOS / Why it is preferable to use non-drug-eluting stents
by: Rosa Lázaro García, et al.
Published: (2013-10-01)

Role of Intracellular Na<sup>+</sup> in the Regulation of [Ca<sup>2+</sup>]<sub>i</sub> in the Rat Suprachiasmatic Nucleus Neurons
by: Ruo-Ciao Cheng, et al.
Published: (2019-09-01)

Stent thrombosis: Prevention and management
by: Rajendra Kumar Jain, et al.
Published: (2014-01-01)

One-Year Outcome of Everolimus-Eluting Stents versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
by: Mohammad Alidoosti, et al.
Published: (2016-10-01)

Differential Factors for Predicting Outcomes in Left Main versus Non-Left Main Coronary Bifurcation Stenting
by: Jung-Joon Cha, et al.
Published: (2021-07-01)

The NUNAtak Ice Thinning (NUNAIT) Calculator for Cosmonuclide Elevation Profiles
by: Ángel Rodés
Published: (2021-08-01)

Interim Results of the Basket of Real-World Randomised Clinical PRISM Trials for M’Sure-S, a Next-Generation Sirolimus-Eluting Stent, Versus Eliminator, an Everolimus-Eluting Stent
by: Marc Silvestri, et al.
Published: (2018-09-01)

Live-Cell Imaging of Physiologically Relevant Metal Ions Using Genetically Encoded FRET-Based Probes
by: Helmut Bischof, et al.
Published: (2019-05-01)

Gene Delivery from Stents for Prevention of In Stent Restenosis
by: Ilia Fishbein, et al.
Published: (2016-12-01)

Characteristics of B-lymphocyte subpopulations in renal transplant recipients
by: S. V. Zybleva, et al.
Published: (2021-06-01)

Initial Experience With the Next-Generation Resolute Onyx Zotarolimus-Eluting Stent in Symptomatic Intracranial Atherosclerotic Disease
by: Ameer E. Hassan, et al.
Published: (2020-09-01)

Comparison of the Major Clinical Outcomes for the Use of Endeavor® and Resolute Integrity® Zotarolimus-Eluting Stents During a Three-Year Follow-up
by: Yong Hoon Kim, et al.
Published: (2020-02-01)

Piperlongumine-Eluting Gastrointestinal Stent Using Reactive Oxygen Species-Sensitive Nanofiber Mats for Inhibition of Cholangiocarcinoma Cells
by: Hyung Ha Jang, et al.
Published: (2019-02-01)

Comparison between a Bare–Metal Stents and Drug Eluting Stents in patients undergoing Percutaneous Coronary Intervention.
by: Khaled Alsayed
Published: (2020-10-01)

Role of Second-Generation Drug-Eluting Stents and Bypass Grafting in Coronary Artery Disease: A Systematic Review and Meta-analysis
by: Linjuan Guo, MD, et al.
Published: (2017-02-01)

Comparison of drug-eluting and bare-metal stents in patients with saphenous vein graft stenosis
by: Ahmed Zayed, et al.
Published: (2020-01-01)

Comparative study of serum Na<sup>+ </sup>and K<sup>+ </sup> levels in senile cataract patients and normal individuals
Published: (2004-08-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
by: Omar A. Meelu, MS, et al.
Published: (2017-03-01)

Cannot write session to /tmp/vufind_sessions/sess_lu9arao7nclftppu1i7n3dl48v